Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management
W Ambrosius, S Michalak, W Kozubski… - International journal of …, 2020 - mdpi.com
Myelin oligodendrocyte glycoprotein (MOG)-associated disease (MOGAD) is a rare,
antibody-mediated inflammatory demyelinating disorder of the central nervous system …
antibody-mediated inflammatory demyelinating disorder of the central nervous system …
Clinical and neuroimaging findings in MOGAD–MRI and OCT
Myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are rare in
both children and adults, and have been recently suggested to be an autoimmune …
both children and adults, and have been recently suggested to be an autoimmune …
Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody‐positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody …
EC Li, Y Zheng, MT Cai, QL Lai, GL Fang, BQ Du… - …, 2022 - Wiley Online Library
Seizure is one of the manifestations of central nervous system inflammatory demyelinating
diseases, which mainly include multiple sclerosis (MS), aquaporin 4 antibody‐positive …
diseases, which mainly include multiple sclerosis (MS), aquaporin 4 antibody‐positive …
Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behçet's syndrome
A Bettiol, M Becatti, E Silvestri… - Clinical & …, 2021 - academic.oup.com
Behçet's syndrome (BS) is a systemic vasculitis with several clinical manifestations.
Neutrophil hyperactivation mediates vascular BS pathogenesis, via both a massive reactive …
Neutrophil hyperactivation mediates vascular BS pathogenesis, via both a massive reactive …
Immune mechanism of epileptogenesis and related therapeutic strategies
MJ Aguilar-Castillo, P Cabezudo-García… - Biomedicines, 2022 - mdpi.com
Immunologic and neuroinflammatory pathways have been found to play a major role in the
pathogenesis of many neurological disorders such as epilepsy, proposing the use of novel …
pathogenesis of many neurological disorders such as epilepsy, proposing the use of novel …
Clinical and imaging features of patients with encephalitic symptoms and myelin oligodendrocyte glycoprotein antibodies
J Wang, Z Qiu, D Li, X Yang, Y Ding, L Gao… - Frontiers in …, 2021 - frontiersin.org
Background Myelin oligodendrocyte glycoprotein-antibody (MOG-ab)-associated disease
(MOGAD) has highly heterogenous clinical and imaging presentations, in which encephalitis …
(MOGAD) has highly heterogenous clinical and imaging presentations, in which encephalitis …
The cross talk between underlying mechanisms of multiple sclerosis and epilepsy may provide new insights for more efficient therapies
Despite the significant differences in pathological background of neurodegenerative
diseases, epileptic seizures are a comorbidity in many disorders such as Huntington …
diseases, epileptic seizures are a comorbidity in many disorders such as Huntington …
[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: A novel phenotype
S Lin, W Long, J Wen, Q Su, J Liao, Z Hu - Multiple Sclerosis and Related …, 2022 - Elsevier
Background Myelin oligodendrocyte glycoprotein (MOG) antibodies mediate inflammatory
demyelinating diseases of the central nervous system. This study aimed to understand the …
demyelinating diseases of the central nervous system. This study aimed to understand the …
Serum neurofilament light chain in adult and pediatric patients with myelin oligodendrocyte glycoprotein antibody‐associated disease: correlation with relapses and …
W Luo, Y Chen, S Mao, J Jin, C Liu… - Journal of …, 2022 - Wiley Online Library
Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) causes major
disability as a consequence of recurrent demyelinating events and neuronal loss …
disability as a consequence of recurrent demyelinating events and neuronal loss …